These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9173266)

  • 1. Prediction of liver fibrosis according to serum collagen VI level in children with cystic fibrosis.
    Gerling B; Becker M; Staab D; Schuppan D
    N Engl J Med; 1997 May; 336(22):1611-2. PubMed ID: 9173266
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
    Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
    J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of measuring the level of procollagen type III peptide in the evaluation of liver fibrosis in children].
    Swiatkowska E; Socha J; Bogoniowska Z; Leśniewska A; Malenta G; Oralewska B
    Pol Tyg Lek; 1988 Apr; 43(14):441-3. PubMed ID: 3412979
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic complications of mucoviscidosis].
    Feigelson J; Pecau Y; Fontaine JL; Navarro J
    Med Chir Dig; 1976; 5(7):365-71. PubMed ID: 1018531
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathomorphosis of cystic fibrosis. Current medical and surgical problems in the improved prognosis of cystic fibrosis].
    Romano C
    Minerva Pediatr; 1981 Jul; 33(14):677-702. PubMed ID: 7027012
    [No Abstract]   [Full Text] [Related]  

  • 8. alpha-Fetoprotein and cystic fibrosis.
    Beaudry PH; Bergsteinsson H; Dupont C; Wong HC; Shuster J; Desmond K; Gold P
    Clin Invest Med; 1982; 5(1):45-7. PubMed ID: 6180858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic cirrhosis].
    Popescu V; Arion C
    Rev Pediatr Obstet Ginecol Pediatr; 1980; 29(3):193-218. PubMed ID: 6781028
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastrointestinal complications in cystic fibrosis.
    Redmond AO
    Practitioner; 1980 Mar; 224(1341):295-9. PubMed ID: 7403010
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatobiliary disorders in cystic fibrosis].
    van de Meeberg PC; Bijleveld CM; Heijerman HG; Houwen RH; Sinaasappel M; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1357-60. PubMed ID: 8035893
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
    Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver involvement in cystic fibrosis. A report of 9 cases.
    Schwarz HP; Kraemer R; Thurnheer U; Rossi E
    Helv Paediatr Acta; 1978 Nov; 33(4-5):351-64. PubMed ID: 711497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of transient elastography in noninvasive assessment in children's hepatic fibrosis].
    Breton E; Bridoux-Henno L; Guyader D; Daniélou H; Jouan H; Beuchée A; Nousbaum JB; Dabadie A
    Arch Pediatr; 2009 Jul; 16(7):1005-10. PubMed ID: 19446446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium and glutathione peroxidase levels in cystic fibrosis.
    Lloyd-Still JD; Ganther HE
    Pediatrics; 1980 May; 65(5):1010-2. PubMed ID: 7367113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of cefsulodin in children with and without cystic fibrosis treated for infectious diseases.
    Michalsen H; Bergan T; Solberg R
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):685-7. PubMed ID: 3807469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum markers of liver fibrosis].
    Schuppan D; Jax C; Hahn EG
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1213-8. PubMed ID: 10572522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.